Milestone Scientific Inc. (MLSS) Insider Trading Activity

AMEX$0.2849
Market Cap
$22.21M
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
682 of 883
Rank in Industry
39 of 49

MLSS Insider Trading Activity

MLSS Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
0
Sells
$471,737
34
100

Related Transactions

BP4 S.r.l.10 percent owner
0
$0
34
$471,737
$-471,737

About Milestone Scientific Inc.

Milestone Scientific Inc. designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. The company also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances; and disposable injection handpiece for the tactile control during the injection. In addition, it provides CompuFlo Epidural, a computer controlled anesthesia system for use in various medical applications. Further, the company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Livingston, New Jersey.

Insider Activity of Milestone Scientific Inc.

Over the last 12 months, insiders at Milestone Scientific Inc. have bought $0 and sold $471,737 worth of Milestone Scientific Inc. stock.

On average, over the past 5 years, insiders at Milestone Scientific Inc. have bought $170,756 and sold $297,228 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 55,326 shares for transaction amount of $27,663 was made by GOLDMAN NEAL I (director) on 2022‑12‑19.

List of Insider Buy and Sell Transactions, Milestone Scientific Inc.

2025-10-24SaleBP4 S.r.l.10 percent owner
100,000
0.1316%
$0.44
$43,980
-27.88%
2025-10-23SaleBP4 S.r.l.10 percent owner
80,000
0.103%
$0.43
$34,416
-30.64%
2025-10-22SaleBP4 S.r.l.10 percent owner
14,427
0.0191%
$0.45
$6,488
-31.64%
2025-10-21SaleBP4 S.r.l.10 percent owner
40,000
0.0503%
$0.44
$17,592
-33.53%
2025-10-20SaleBP4 S.r.l.10 percent owner
24,034
0.032%
$0.45
$10,880
-31.74%
2025-10-14SaleBP4 S.r.l.10 percent owner
30,000
0.0389%
$0.54
$16,185
-43.16%
2025-10-13SaleBP4 S.r.l.10 percent owner
10,000
0.013%
$0.55
$5,500
-44.05%
2025-10-10SaleBP4 S.r.l.10 percent owner
10,158
0.0137%
$0.55
$5,588
-41.82%
2025-10-08SaleBP4 S.r.l.10 percent owner
30,000
0.0375%
$0.47
$13,950
-35.96%
2025-10-07SaleBP4 S.r.l.10 percent owner
10,000
0.0127%
$0.45
$4,500
-32.85%
2025-10-03SaleBP4 S.r.l.10 percent owner
19,210
0.0242%
$0.45
$8,636
-30.65%
2025-09-11SaleBP4 S.r.l.10 percent owner
10,000
0.0128%
$0.59
$5,940
-45.74%
2025-07-17SaleBP4 S.r.l.10 percent owner
10,000
0.0132%
$0.64
$6,400
-37.11%
2025-07-08SaleBP4 S.r.l.10 percent owner
11,489
0.0153%
$0.69
$7,933
-37.88%
2025-07-07SaleBP4 S.r.l.10 percent owner
30,558
0.039%
$0.68
$20,804
-39.07%
2025-07-03SaleBP4 S.r.l.10 percent owner
50,853
0.0648%
$0.67
$34,061
-38.11%
2025-06-30SaleBP4 S.r.l.10 percent owner
649
0.0008%
$0.65
$422
-34.17%
2025-06-27SaleBP4 S.r.l.10 percent owner
10,000
0.0128%
$0.73
$7,300
-42.33%
2025-06-25SaleBP4 S.r.l.10 percent owner
1,300
0.0017%
$0.77
$1,001
-43.54%
2025-06-24SaleBP4 S.r.l.10 percent owner
10,000
0.013%
$0.81
$8,054
-46.17%
Total: 168
*Gray background shows transactions not older than one year

Insider Historical Profitability

9.66%
BP4 S.r.l.10 percent owner
8896765
11.3149%
$2.51M134
<0.0001%
Trombetta Giandomenico
9921039
12.6175%
$2.8M36
<0.0001%
OSSER LEONARDdirector
4606882
5.859%
$1.3M644
+22.7%
GOLDMAN NEAL Idirector
1433003
1.8225%
$404,823.3590
+18.43%
D'Agostino JosephCFO & COO
903587
1.1492%
$255,263.33024
McGeehan Michaeldirector
575273
0.7316%
$162,514.6214
+51.39%
SCHILLER LEONARD M
306356
0.3896%
$86,545.5721
+0.98%
Bernhard Lesliedirector
79268
0.1008%
$22,393.21012
Zelnick Edward J.director
40000
0.0509%
$11,300.0020
+26.08%
Serna Cardenas Pablo Felipedirector
33043
0.042%
$9,334.65016
Goldberger Daniel SPresident and CEO
10000
0.0127%
$2,825.0020
<0.0001%
Fuller Jeffreydirector
0
0%
$001
*Gray background shows insiders who have made transactions during last year

MLSS Institutional Investors: Active Positions

Increased Positions9+21.43%311,603+6.99%
Decreased Positions15-35.71%243,401-5.46%
New Positions5New214,635New
Sold Out Positions5Sold Out76,685Sold Out
Total Postitions36-14.29%5M+1.53%

MLSS Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Vanguard Group Inc$695.002.98%2.36M+172,824+7.92%2025-09-30
Geode Capital Management, Llc$180.000.77%611,070+60,661+11.02%2025-09-30
State Street Corp$41.000.18%139,88500%2025-09-30
Susquehanna International Group, Llp$36.000.16%122,139-37,376-23.43%2025-09-30
Mariner, Llc$36.000.15%121,750-75,000-38.12%2025-09-30
Bridgeway Capital Management, Llc$34.000.15%116,800-238,700-67.14%2025-09-30
Carnegie Investment Counsel$34.000.15%116,175-48,434-29.42%2025-09-30
Northern Trust Corp$33.000.14%112,61500%2025-09-30
Lpl Financial Llc$31.000.13%104,94500%2025-09-30
World Investment Advisors$30.000.13%100,00000%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.